Business Description
Realcan Pharmaceutical Group Co Ltd
NAICS : 325412
ISIN : CNE1000013X5
Share Class Description:
SZSE:002589: Class ACompare
Compare
Traded in other countries / regions
002589.China IPO Date
2011-06-10Description
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.79 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 0.93 | |||||
Debt-to-EBITDA | 48.59 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.84 | |||||
Beneish M-Score | -2.24 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -34.2 | |||||
3-Year EBITDA Growth Rate | -40.7 | |||||
3-Year FCF Growth Rate | 2.7 | |||||
3-Year Book Growth Rate | -10 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.42 | |||||
9-Day RSI | 50.07 | |||||
14-Day RSI | 45.99 | |||||
6-1 Month Momentum % | -25.23 | |||||
12-1 Month Momentum % | -29.41 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.09 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 45.75 | |||||
Days Sales Outstanding | 180.22 | |||||
Days Payable | 295.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.57 | |||||
Forward Dividend Yield % | 0.57 | |||||
5-Year Yield-on-Cost % | 0.59 | |||||
Shareholder Yield % | 5.21 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 9.41 | |||||
Operating Margin % | -1.58 | |||||
Net Margin % | 0.18 | |||||
FCF Margin % | -4.39 | |||||
ROE % | 0.26 | |||||
ROA % | 0.08 | |||||
ROIC % | 0.18 | |||||
ROC (Joel Greenblatt) % | 4.17 | |||||
ROCE % | 1.77 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 253.33 | |||||
PE Ratio without NRI | 108.57 | |||||
Shiller PE Ratio | 36.75 | |||||
PS Ratio | 0.43 | |||||
PB Ratio | 0.63 | |||||
Price-to-Tangible-Book | 0.72 | |||||
EV-to-EBIT | 42.93 | |||||
EV-to-EBITDA | 42.93 | |||||
EV-to-Revenue | 0.56 | |||||
EV-to-FCF | -12.82 | |||||
Price-to-Projected-FCF | 0.74 | |||||
Price-to-Median-PS-Value | 0.81 | |||||
Price-to-Graham-Number | 1.85 | |||||
Price-to-Net-Current-Asset-Value | 8.77 | |||||
Earnings Yield (Greenblatt) % | 2.33 | |||||
FCF Yield % | -10.22 | |||||
Forward Rate of Return (Yacktman) % | -29.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Realcan Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 7,980.099 | ||
EPS (TTM) (Â¥) | 0.009 | ||
Beta | 0.44 | ||
Volatility % | 32.99 | ||
14-Day RSI | 45.99 | ||
14-Day ATR (Â¥) | 0.086107 | ||
20-Day SMA (Â¥) | 2.268 | ||
12-1 Month Momentum % | -29.41 | ||
52-Week Range (Â¥) | 2.05 - 3.9 | ||
Shares Outstanding (Mil) | 1,504.71 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Realcan Pharmaceutical Group Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Realcan Pharmaceutical Group Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Realcan Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Realcan Pharmaceutical Group Co Ltd(SZSE:002589)'s stock price today?
The current price of SZSE:002589 is ¥2.28. The 52 week high of SZSE:002589 is ¥3.90 and 52 week low is ¥2.05.
When is next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589)?
The next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is .
Does Realcan Pharmaceutical Group Co Ltd(SZSE:002589) pay dividends? If so, how much?
The Dividend Yield %  of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is 0.57% (As of Today), Highest Dividend Payout Ratio of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) was 0.34. The lowest was 0.05. And the median was 0.08. The  Forward Dividend Yield % of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is 0.57%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |